Phacilitate Leaders World

Conference speakers

Kourosh Saeb Parsy

Kourosh Saeb Parsy

Consultant Transplant Surgeon, Addenbrooke's Hospital, Cambridge
Kourosh Saeb-Parsy is research Group Leader and Transplant surgeon at the University of Cambridge. He performs liver, kidney and pancreas transplants and conducts research into the safety, function and immunogenicity of regenerative cellular therapies for the treatment of a range conditions including diabetes and liver failure. He is the Founder and Managing Director of the biomedical consulting company Excelect Ltd and has extensive commercial experience, including at board level as Chief Medical Officer with several start-ups and multinationals. He is co-founder Bilitech Ltd, a University of Cambridge spin-out company focused on development of cellular and tissue engineering solutions for liver disease. He works at the interface between academic, clinical and commercial organisations to create synergy and deliver maximal benefit to individuals, patients and companies.
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman